Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: Studies in intact and 6-hydroxydopamine-treated rats

Journal of Neurochemistry

Volumn 72, Issue 4, 1999, Pages 1516-1522

  Miller, David W ^a   Abercrombie, Elizabeth D ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Aromatic amino acid decarboxylase; Microdialysis; Parkinson's disease; Tetrodotoxin

Indexed keywords

DOPAMINE; LEVODOPA; OXIDOPAMINE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DISEASE SEVERITY; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC ACTIVITY; DRUG EFFECT; DRUG MECHANISM; MALE; MICRODIALYSIS; NERVE CONDUCTION; NERVE ENDING; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOPAMINE UPTAKE INHIBITORS; EXTRACELLULAR SPACE; LEVODOPA; MALE; MICRODIALYSIS; NERVE DEGENERATION; OXIDOPAMINE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHOMIMETICS; TETRODOTOXIN;

ANIMALIA;

EID: 0033054705     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.721516.x     Document Type: Article

References (28)

1. Abercrombie E. D. and Finlay J. M. (1991) Monitoring extracellular norepinephrine in brain using in vivo microdialysis and HPLC-EC, in Microdialysis in the Neurosciences (Robinson T. E. and Justice J. B. Jr., eds), pp. 253-274. Elsevier, Amsterdam.
2. Abercrombie E. D. and Zigmond M. J. (1990) In vivo neurochemical analysis of exogenously administered L-DOPA: implications for treatment of Parkinson's disease, in Basal Ganglia, Vol. III (Bernardi G., Carpenter M. B., and Di Chiara G., eds), pp. 673-682. Plenum Press, New York.
3. Abercrombie E. D., Bonatz A. E., and Zigmond M. J. (1990) Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525, 36-44.
4. Acquas E., Carboni E., de Ree R. H. A., Da Prada M., and Di Chiara G. (1992) Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592. J. Neurochem. 59, 326-330.
5. Aral R., Karasawa N., and Nagatsu I. (1996) Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study. Brain Res. 706, 177-179.
6. Bunney B. S., Aghajanian G. K., and Roth R. H. (1973) Comparison of effects of L-DOPA, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat. New Biol. 245, 123-125.
7. De Boer P., Wachtel S. R., and Abercrombie E. D. (1994) Biochemistry and pharmacology of L-DOPA in relation to basal ganglia circuitry, in Basal Ganglia, Vol. IV (Percheron G., McKenzie J. S., and Feger J., eds), pp. 395-401. Plenum Press, New York.
8. Garris P. A. and Wightman R. M. (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci. 14, 442-450.
9. Hefti F., Melamed E., and Wurtman R. J. (1981) The site of dopamine formation in rat striatum after L-DOPA administration. J. Pharmacol. Exp. Ther. 217, 189-197.
10. Hollister A. S., Breese G. R., and Mueller R. A. (1979) Role of monoamine neuronal systems in L-dihydroxyphenylalanine-stimulated activity. J. Pharmacol. Exp. Ther. 208, 37-43.
11. Kang U. J., Park D. H., Wessel T., Baker H., and Joh T. H. (1992) DOPA-decarboxylation in the striata of rats with unilateral substantia nigra lesions. Neurosci. Lett. 147, 53-57.
12. Koshimura K., Ohue T., Akiyama Y., Itoh A., and Miwa S. (1992) L-DOPA administration enhances exocytotic dopamine release in vivo in the rat striatum. Life Sci. 51, 747-755.
13. Li X.-M., Juorio A. V., Paterson I. A., Waltz W., Zhu M.-Y., and Boulton A. A. (1992) Gene expression of aromatic L-amino acid decarboxylase in cultured rat glial cells. J. Neurochem. 59, 1172-1175.
14. Lloyd K. G., Davidson L., and Hornykiewicz O. (1975) The neurochemistry of Parkinson's disease: effect of L-DOPA therapy. J. Pharmacol. Exp. Ther. 195, 453-464.
15. Melamed E. (1988) Mechanism of action of exogenous L-DOPA: is it a physiological therapy for Parkinson's disease, in Parkinson's Disease and Movement Disorders (Jankovic J. and Tolosa E., eds), pp. 87-94. Urban and Schwarzenberg, Baltimore.
16. Melamed E., Hefti F., and Wurtman R. J. (1980) Nonaminergic striatal neurons convert exogenous L-DOPA to dopamine in parkinsonism. Ann. Neurol. 8, 558-563.
17. Melamed E., Hefti F., Pettibone D. J., Liebman J., and Wurtman R. J. (1981) Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-DOPA in parkinsonism. Neurology 31, 651-655.
18. Miller D. W. and Abercrombie E. D. (1998) 5-HT terminals as primary source of extracellular dopamine formed from exogenous L-DOPA in striatum of 6-OHDA-treated rats. Soc. Neurosci. Abstr. 24, 1989.
19. Nakazato T. and Akiyama A. (1992) Decarboxylation of exogenous L-3,4-dihydroxyphenylalanine in rat striatum as studied by in vivo voltammetry. J. Neurochem. 58, 121-127.
20. Ng K. Y., Chase T. N., Colburn R. W., and Kopin I. J. (1972) L-DOPA in parkinsonism: a possible mechanism of action. Neurology 22, 688-696.
21. Nicholson C. and Rice M. E. (1991) Diffusion of ions and transmitters in the brain cell microenvironment, in Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission (Fuxe K. and Agnate L. F., eds), pp. 279-294. Raven Press, New York.
22. Nissbrandt H., Engberg G., and Pileblad E. (1991) The effects of GBR-12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra. Naunyn Schmiedebergs Arch. Pharmacol. 344, 16-28.
23. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Orlando.
24. Schoenfeld R. I. and Uretsky N. J. (1973) Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats. J. Pharmacol. Exp. Ther. 186, 616-624.
25. Trugman J. M. and Wooten G. F. (1986) The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra. Brain Res. 379, 264-274.
26. Wachtel S. R. and Abercrombie E. D. (1994) L-3,4-Dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors. J. Neurochem. 63, 108-117.
27. Yahr M. D., Wolf A., Antunes J.-L., Miyoshi K., and Duffy P. (1972) Autopsy findings in parkinsonism following treatment with levo-dopa. Neurology 20 (Suppl.), 56-71.
28. Zetterström T., Herrera-Marschitz M., and Ungerstedt U. (1986) Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res. 376, 1-7.